[6]
This is a proceeding pursuant to subsection 6(1) of the
Patented Medicines (Notice of Compliance) Regulations
, SOR/93-133 as amended (
NOC Regulations
). Janssen-Ortho Inc. (Janssen) and Daiichi Sankyo Company Limited (Daiichi) have applied to the Federal Court seeking an Order prohibiting the Minister of Health from issuing a Notice of Compliance (NOC) under C.08.004 of the
Food and Drug Regulations
, C.R.C., c. 870, to Apotex Inc. (Apotex) relating to an antimicrobial drug, known as levofloxacin, in the form of 250, 500 and 700 mg tablet strengths, until after expiry of Canadian Patent No. 1,304,080 ('080 patent).
III. Background
The patent at issue